Navigation Links
Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer
Date:5/13/2008

PHILADELPHIA, May 13 /PRNewswire-USNewswire/ -- In women at increased risk for breast cancer, adding a screening ultrasound examination to routine mammography revealed 28 percent more cancers than mammography alone. However, the additional ultrasound exam substantially increased the rates of false positive findings and unnecessary biopsies, according to an American College of Radiology Imaging Network (ACRIN) study published in the May 14, 2008 issue of the Journal of American Medical Association.

This ACRIN study enrolled 2,809 women at increased risk for breast cancer at 21 sites and 2,637 of these women were eligible for analysis. The criteria used to determine an increased breast cancer risk included: participant age of 25 years or older, dense breasts, prior atypical breast biopsy, personal and/or or moderate family history of breast cancer. The study was made possible through funding from a novel private-public partnership between the Avon Foundation and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

Forty women were diagnosed with breast cancer within 12 months of the initial screening. Mammography alone revealed 20 cancers (50 percent of all cancers detected) for a cancer detection rate of 7.6 women per 1,000 women screened, though one cancer was dismissed. The combination of mammography plus screening ultrasound revealed 31 cancers (78 percent of all cancers detected) for a cancer detection rate of 11.8 women per 1,000 women screened. Eight of the 40 cancers were not seen with either mammography or ultrasound at the time of the initial screen, but were discovered later during the twelve month period for a rate of three cancers missed per 1,000 women screened.

The risk of incurring an unnecessary biopsy due to a false positive exam result from the supplemental screening ultrasound was also substantially increased in this study. Mammography alone prompted an unnecessary biopsy for one in 40 women in this study. The combination of mammography and ultrasound screening prompted an unnecessary biopsy for one in 10 women, or four times more women having an unnecessary biopsy.

According to the study's principal investigator, Wendie Berg, M.D., Ph.D., a radiologist specializing in breast imaging with American Radiology Services at Johns Hopkins Green Spring, Lutherville, Md., "The study results confirm that screening ultrasound in combination with mammography detects more cancers than mammography alone in women at increased risk for breast cancer. However, this benefit comes with the added risk of a false positive result. If we are going to offer screening ultrasound, we need to inform women of the substantial risk of receiving an unnecessary biopsy."

The study's statistician, Jeffrey Blume, Ph.D., associate professor and deputy director of the ACRIN Biostatistics and Data Management Center at Brown University in Providence, R.I., emphasized the reliability of these results: "Rigorous, well controlled trials like this one - where participants uniformly undergo both screening exams in a randomized order and investigators interpreting one exam are masked to the results of the other - yield the highest level of medical evidence. A study as large as this one could not have been completed without the ongoing support and cooperation of NCI and Avon."

The American Cancer Society recently recommended that certain women at very high risk for breast cancer be screened with magnetic resonance imaging (MRI) in addition to mammography, and these results do not change that recommendation. Women who do have screening MRI do not need screening ultrasound. Women who are at increased risk, who are currently undergoing mammographic screening and are not recommended for MRI, or for whom it is not available or not tolerated, may wish to consider adding screening ultrasound. Women should talk with their doctor about their breast cancer risk profile and whether a screening ultrasound exam supplemental to mammography might be beneficial, keeping in mind the potential for a false positive result and an unnecessary biopsy. At present, there is a limited supply of trained personnel and facilities who offer screening ultrasound. Women also should consult their health insurance policy regarding the coverage for breast cancer screening options. An annual mammogram is still recommended: neither MRI nor ultrasound is meant to replace mammography.

The study continues to follow participants to examine the potential benefit of routine annual combination screening of mammography and ultrasound.

For a listing of participating sites, please visit:

http://www.acrin.org/PROTOCOLSUMMARYTABLE/PROTOCOL6666/6666PARTICIPATIN GSITES/tabid/169/Default.aspx

Today, there are more than 33,000 radiologists practicing in the United States. As the medical doctors who specialize in diagnosing and treating disease and injury through medical imaging, radiologists are the experts in imaging care. Most radiologists have completed at least 13 years of training, including medical school, licensing, a four-year residency, and often a one- to two-year fellowship of specialized training.


'/>"/>
SOURCE American College of Radiology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
5. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
6. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
7. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
8. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
11. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... According to a new market research report "Process ... and Services (Analyzers, Probes & Sensors), End - User (Pharmaceutical Manufacturers, CRO ... market is poised to reach USD 3.30 Billion by 2021 from USD ... 2021. Continue Reading ... ...
(Date:2/22/2017)... -- Des scanners sur smartphone destinés aux professionnels de la ... , au Moyen-Orient et en Afrique  ... Clarius Mobile Health , une société de santé numérique dont ... Canada , a annoncé aujourd,hui qu,elle a reçu la certification ... C3 et L7, destinés à être utilisés par des professionnels de la ...
(Date:2/21/2017)... , Feb. 21, 2017 ... specialized versions are used to monitor physiological signs. These ... remote patient monitors. Remote patient monitoring is one of ... patient monitoring equipment in the market. Hence, vendors are ... smartphones and applications, which can send test results on ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s ... spine practices, is featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon ... small number of neurosurgeons in Michigan performing minimally invasive back surgery that often ...
(Date:2/22/2017)... ... February 22, 2017 , ... A product of digesting ... to derive a heart-protective benefit from eating soy foods, while others do not, a ... who are able to produce equol—a substance made by some types of “good” gut ...
(Date:2/22/2017)... ... 22, 2017 , ... Forty-five percent of American respondents feel ... members or friends have also commented about their poor hearing. However, only 13 ... One reason, suggested by 89 percent of American respondents, is that they don’t ...
(Date:2/22/2017)... ... , ... Super-Sod will attend the Athens Home Show with a brand new ... from Super-Sod’s simple Athens Home Show booth of 2016, this year’s exhibit space includes ... Chris Roquemore constructed furniture from recycled pallet wood at the Super-Sod farm in Fort ...
(Date:2/22/2017)... Troy, NY (PRWEB) , ... February 22, 2017 , ... ... effort — especially for hospitals and health systems. Smith & Jones’ delves into this ... In this episode, President of Smith & Jones David Vener meets up with social ...
Breaking Medicine News(10 mins):